Multimodality Imaging in Primary Progressive Aphasia

References

1. 1.↵
   1. Patel KP,
   2. Wymer DT,
   3. Bhatia VK, et al

   . Multimodality imaging of dementia: clinical importance and role of integrated anatomic and molecular imaging. Radiographics 2020;40:200–22 doi:10.1148/rg.2020190070 pmid:31917652

   CrossRefPubMed
2. 2.↵
   1. Brown RKJ,
   2. Bohnen NI,
   3. Wong KK, et al

   . Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics 2014;34:684–701 doi:10.1148/rg.343135065 pmid:24819789

   CrossRefPubMed
3. 3.↵
   1. Irwin DJ

   . Tauopathies as clinicopathological entities. Parkinsonism Relat Disord 2016;22:S29–33 doi:10.1016/j.parkreldis.2015.09.020 pmid:26382841

   CrossRefPubMed
4. 4.↵
   1. Montembeault M,
   2. Brambati SM,
   3. Gorno-Tempini ML, et al

   . Clinical, anatomical, and pathological features in the three variants of primary progressive aphasia: a review. Front Neurol 2018;9:692 doi:10.3389/fneur.2018.00692 pmid:30186225

   CrossRefPubMed
5. 5.↵
   1. Spinelli EG,
   2. Mandelli ML,
   3. Miller ZA, et al

   . Typical and atypical pathology in primary progressive aphasia variants. Ann Neurol 2017;81:430–43 doi:10.1002/ana.24885 pmid:28133816

   CrossRefPubMed
6. 6.↵
   1. Gorno-Tempini ML,
   2. Hillis AE,
   3. Weintraub S, et al

   . Classification of primary progressive aphasia and its variants. Neurology 2011;76:1006–14 doi:10.1212/WNL.0b013e31821103e6 pmid:21325651

   CrossRefPubMed
7. 7.↵
   1. Mesulam MM

   . Primary progressive aphasia: a language-based dementia. N Engl J Med 2003;349:1535–42 doi:10.1056/NEJMra022435 pmid:14561797

   CrossRefPubMed
8. 8.↵
   1. Mesulam M,
   2. Wieneke C,
   3. Rogalski E, et al

   . Quantitative template for subtyping primary progressive aphasia. Arch Neurol 2009;66:1545–51 doi:10.1001/archneurol.2009.288 pmid:20008661

   CrossRefPubMed
9. 9.↵
   1. Sitek EJ,
   2. Narozańska E,
   3. Brockhuis B, et al

   . Neuroimaging in the differential diagnosis of primary progressive aphasia: illustrative case series in the light of new diagnostic criteria. Polish J Radiol 2014;79:251–58 doi:10.12659/PJR.890320 pmid:25343001

   CrossRefPubMed
10. 10.↵
    1. Gorno-Tempini ML,
    2. Dronkers NF,
    3. Rankin KP, et al

    . Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55:335–46 doi:10.1002/ana.10825 pmid:14991811

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Marshall CR,
    2. Hardy CJ,
    3. Volkmer A, et al

    . Primary progressive aphasia: a clinical approach. J Neurol 2018;265:1474–90 doi:10.1007/s00415-018-8762-6 pmid:29392464

    CrossRefPubMed
12. 12.↵
    1. Grossman M

    . Primary progressive aphasia: clinicopathological correlations. Nat Rev Neurol 2010;6:88–97 doi:10.1038/nrneurol.2009.216 pmid:20139998

    CrossRefPubMed
13. 13.↵
    1. Butts AM,
    2. Machulda MM,
    3. Duffy JR, et al

    . Neuropsychological profiles differ among the three variants of primary progressive aphasia. J Int Neuropsychol Soc 2015;21:429–35 doi:10.1017/S1355617715000399 pmid:26067425

    CrossRefPubMed
14. 14.↵
    1. Magnin E,
    2. Démonet JF,
    3. Wallon D, et al

    ; on behalf of ePLM orators. Primary progressive aphasia in the Network of French Alzheimer Plan Memory Centers. J Alzheimers Dis 2016;54:1459–71 doi:10.3233/JAD-160536 pmid:27589533

    CrossRefPubMed
15. 15.↵
    1. Teichmann M,
    2. Kas A,
    3. Boutet C, et al

    . Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation. Brain 2013;136:3474–88 doi:10.1093/brain/awt266 pmid:24108322

    CrossRefPubMed
16. 16.↵
    1. Lundeen TF,
    2. Seibyl JP,
    3. Covington MF, et al

    . Signs and artifacts in amyloid PET. Radiographics 2018;38:2123–33 doi:10.1148/rg.2018180160 pmid:30422768

    CrossRefPubMed
17. 17.↵
    1. Bergeron D,
    2. Gorno-Tempini ML,
    3. Rabinovici G, et al

    . Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia. Ann Neurol 2018;84:729–40 doi:10.1002/ana.25333 pmid:30255971

    CrossRefPubMed
18. 18.↵
    1. Botha H,
    2. Duffy JR,
    3. Whitwell JL, et al

    . Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech. Cortex 2015;69:220–36 doi:10.1016/j.cortex.2015.05.013 pmid:26103600

    CrossRefPubMed
19. 19.↵
    1. Rabinovici GD,
    2. Jagust WJ,
    3. Furst AJ, et al

    . AB amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008;64:388–401 doi:10.1002/ana.21451 pmid:18991338

    CrossRefPubMed
20. 20.↵
    1. Beyer L,
    2. Brendel M

    . Imaging of tau pathology in neurodegenerative diseases: an update. Semin Nucl Med 2021;51:253–63 doi:10.1053/j.semnuclmed.2020.12.004 pmid:33353724

    CrossRefPubMed
21. 21.↵
    1. Josephs KA,
    2. Martin PR,
    3. Botha H, et al

    . [18 F]AV-1451 tau-PET and primary progressive aphasia. Ann Neurol 2018;83:599–611 doi:10.1002/ana.25183 pmid:29451323

    CrossRefPubMed
22. 22.↵
    1. Mueller A,
    2. Bullich S,
    3. Barret O, et al

    . Tau PET imaging with 18F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study. J Nucl Med 2020;61:911–19 doi:10.2967/jnumed.119.236224 pmid:31712323

    CrossRefPubMed
23. 23.↵
    1. Xia C,
    2. Makaretz SJ,
    3. Caso C, et al

    . Association of in vivo [18F]AV-1451 tau PET imaging results with cortical atrophy and symptoms in typical and atypical Alzheimer disease. JAMA Neurol 2017;74:427–36 doi:10.1001/jamaneurol.2016.5755 pmid:28241163

    CrossRefPubMed
24. 24.↵
    1. Werry EL,
    2. Bright FM,
    3. Piguet O, et al

    . Recent developments in TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders. Int J Mol Sci 2019;20:1–21 doi:10.3390/ijms20133161 pmid:31261683

    CrossRefPubMed
25. 25.↵
    1. Kim G,
    2. Bolbolan K,
    3. Gefen T, et al

    . Atrophy and microglial distribution in primary progressive aphasia with transactive response DNA-binding protein-43 kDa. Ann Neurol 2018;83:1096–104 doi:10.1002/ana.25240 pmid:29665116

    CrossRefPubMed
26. 26.↵
    1. Hodges J,
    2. Patterson K,
    3. Oxbury S, et al

    . Semantic dementia: progressive fluent aphasia with temporal lobe atrophy. Brain 1992;115:1783–806 doi:10.1093/brain/115.6.1783

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Mahalingam S,
    2. Chen MK

    . Neuroimaging in dementias. Semin Neurol 2019;39:188–99 doi:10.1055/s-0039-1678580 pmid:30925612

    CrossRefPubMed
28. 28.
    1. Masdeu JC

    . Neuroimaging of diseases causing dementia. Neurol Clin 2020;38:65–94 doi:10.1016/j.ncl.2019.08.003 pmid:31761062

    CrossRefPubMed
29. 29.↵
    1. Nasrallah IM,
    2. Wolk DA

    . Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. J Nucl Med 2014;55:2003–11 doi:10.2967/jnumed.114.141416 pmid:25413136

    CrossRefPubMed
30. 30.↵
    1. Villemagne VL,
    2. Barkhof F,
    3. Garibotto V, et al

    . Molecular imaging approaches in dementia. Radiology 2021;298:517–30 doi:10.1148/radiol.2020200028 pmid:33464184

    CrossRefPubMed
31. 31.↵
    1. Clark DG,
    2. Charuvastra A,
    3. Miller BL, et al

    . Fluent versus nonfluent primary progressive aphasia: a comparison of clinical and functional neuroimaging features. Brain Lang 2005;94:54–60 doi:10.1016/j.bandl.2004.11.007 pmid:15896383

    CrossRefPubMed
32. 32.
    1. Collins JA,
    2. Montal V,
    3. Hochberg D, et al

    . Focal temporal pole atrophy and network degeneration in semantic variant primary progressive aphasia. Brain 2017;140:457–71 doi:10.1093/brain/aww313 pmid:28040670

    CrossRefPubMed
33. 33.↵
    1. Panegyres PK,
    2. McCarthy M,
    3. Campbell A, et al

    . Correlative studies of structural and functional imaging in primary progressive aphasia. Am J Alzheimers Dis Other Demen 2008;23:184–91 doi:10.1177/1533317507312621 pmid:18192445

    CrossRefPubMed
34. 34.↵
    1. Thompson SA,
    2. Patterson K,
    3. Hodges JR

    . Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology 2003;61:1196–203 doi:10.1212/01.wnl.0000091868.28557.b8 pmid:14610120

    CrossRefPubMed
35. 35.↵
    1. Landin-Romero R,
    2. Tan R,
    3. Hodges JR

    . An update on semantic dementia: genetics, imaging, and pathology. Alzheimers Res Ther 2016;8:1–9 doi:10.1186/s13195-016-0175-0 pmid:27915998

    CrossRefPubMed
36. 36.↵
    1. Rohrer JD,
    2. Geser F,
    3. Zhou J, et al

    . TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia. Neurology 2010;75:2204–11 doi:10.1212/WNL.0b013e318202038c pmid:21172843

    CrossRefPubMed
37. 37.↵
    1. Seelaar H,
    2. Kamphorst W,
    3. Rosso SM, et al

    . Distinct genetic forms of frontotemporal dementia. Neurology 2008;71:1220–26 doi:10.1212/01.wnl.0000319702.37497.72 pmid:18703462

    CrossRefPubMed
38. 38.↵
    1. Goldman J,
    2. Farmer J,
    3. Wood E, et al

    . Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 2005;65:1817–19 doi:10.1212/01.wnl.0000187068.92184.63 pmid:16344531

    CrossRefPubMed
39. 39.↵
    1. Pottier C,
    2. Ravenscroft TA,
    3. Sanchez-Contreras M, et al

    . Genetics of FTLD: overview and what else we can expect from genetic studies. J Neurochem 2016;138:32–53 doi:10.1111/jnc.13622 pmid:27009575

    CrossRefPubMed
40. 40.↵
    1. Onyike CU,
    2. Diehl-Schmid J

    . The epidemiology of frontotemporal dementia. Int Rev Psychiatry 2013;25:130–37 doi:10.3109/09540261.2013.776523 pmid:23611343

    CrossRefPubMed
41. 41.↵
    1. Clerc MT,
    2. Gunten A

    . Frontotemporal lobar degeneration. Dement Prevalence, Risk Factors Manag Strateg 2014;62:87–114
42. 42.↵
    1. Coyle-Gilchrist ITS,
    2. Dick KM,
    3. Patterson K, et al

    . Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 2016;86:1736–43 doi:10.1212/WNL.0000000000002638 pmid:27037234

    CrossRefPubMed
43. 43.↵
    1. Henry ML,
    2. Beeson PM,
    3. Rapcsak SZ

    . Treatment for anomia in semantic dementia. Semin Speech Lang 2008;29:60–70 doi:10.1055/s-2008-1061625 pmid:18348092

    CrossRefPubMed
44. 44.↵
    1. Sanches C,
    2. Levy R,
    3. Benisty S, et al

    . Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trial. Trials 2019;20:1–15 doi:10.1186/s13063-019-3613-z pmid:31747967

    CrossRefPubMed
45. 45.↵
    1. Chan D,
    2. Fox NC,
    3. Scahill RI, et al

    . Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease. Ann Neurol 2001;49:433–42 doi:10.1002/ana.92 pmid:11310620

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Edwards-Lee T,
    2. Miller B,
    3. Benson D, et al

    . The temporal variant of frontotemporal dementia. Brain 1997;120:1027–40 doi:10.1093/brain/120.6.1027 pmid:9217686

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Josephs KA,
    2. Whitwell JL,
    3. Vemuri P, et al

    . The anatomic correlate of prosopagnosia in semantic dementia. Neurology 2008;71:1628–33 doi:10.1212/01.wnl.0000334756.18558.92 pmid:19001253

    CrossRefPubMed
48. 48.↵
    1. Yang J,
    2. Pan P,
    3. Song W, et al

    . Quantitative meta-analysis of gray matter abnormalities in semantic dementia. J Alzheimers Dis 2012;31:827–33 doi:10.3233/JAD-2012-120736 pmid:22699847

    CrossRefPubMed
49. 49.↵
    1. Rohrer JD,
    2. Warren JD,
    3. Modat M, et al

    . Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology 2009;72:1562–69 doi:10.1212/WNL.0b013e3181a4124e pmid:19414722

    CrossRefPubMed
50. 50.↵
    1. Brambati SM,
    2. Rankin KP,
    3. Narvid J, et al

    . Atrophy progression in semantic dementia with asymmetric temporal involvement: a tensor-based morphometry study. Neurobiol Aging 2009;30:103–11 doi:10.1016/j.neurobiolaging.2007.05.014 pmid:17604879

    CrossRefPubMed
51. 51.↵
    1. Good CD,
    2. Scahill RI,
    3. Fox NC, et al

    . Automatic differentiation of anatomical patterns in the human brain: Validation with studies of degenerative dementias. Neuroimage 2002;17:29–46 doi:10.1006/nimg.2002.1202 pmid:12482066

    CrossRefPubMedWeb of Science
52. 52.↵
    1. Yang Q,
    2. Guo QH,
    3. Bi YC

    . The brain connectivity basis of semantic dementia: a selective review. CNS Neurosci Ther 2015;21:784–92 doi:10.1111/cns.12449 pmid:26336932

    CrossRefPubMed
53. 53.↵
    1. Guo CC,
    2. Gorno-Tempini ML,
    3. Gesierich B, et al

    . Anterior temporal lobe degeneration produces widespread network-driven dysfunction. Brain 2013;136:2979–91 doi:10.1093/brain/awt222 pmid:24072486

    CrossRefPubMed
54. 54.↵
    1. Ranasinghe KG,
    2. Hinkley LB,
    3. Beagle AJ, et al

    . Distinct spatiotemporal patterns of neuronal functional connectivity in primary progressive aphasia variants. Brain 2017;140:2737–51 doi:10.1093/brain/awx217 pmid:28969381

    CrossRefPubMed
55. 55.↵
    1. Olm CA,
    2. Kandel BM,
    3. Avants BB, et al

    . Arterial spin labeling perfusion predicts longitudinal decline in semantic variant primary progressive aphasia. J Neurol 2016;263:1927–38 doi:10.1007/s00415-016-8221-1 pmid:27379517

    CrossRefPubMed
56. 56.↵
    1. Kobayashi R,
    2. Hayashi H,
    3. Kawakatsu S, et al

    . [18F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review. BMC Neurol 2018;18:109 doi:10.1186/s12883-018-1115-3 pmid:30089453

    CrossRefPubMed
57. 57.
    1. Bevan-Jones WR,
    2. Cope TE,
    3. Simon Jones P, et al

    . AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia. J Neurol Neurosurg Psychiatry 2018;89:1032–37 doi:10.1136/jnnp-2017-316402 pmid:28912300

    CrossRefPubMed
58. 58.↵
    1. Smith R,
    2. Santillo AF,
    3. Waldö ML, et al

    . 18 F-Flortaucipir in TDP-43 associated frontotemporal dementia. Sci Rep 2019;9:1–10 doi:10.1038/s41598-018-37186-2 pmid:30626917

    CrossRefPubMed
59. 59.↵
    1. Mormino EC,
    2. Toueg TN,
    3. Azevedo C, et al

    . Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases. Eur J Nucl Med Mol Imaging 2021;48:2233–44 doi:10.1007/s00259-020-04923-7 pmid:32572562

    CrossRefPubMed
60. 60.↵
    1. Schain M,
    2. Kreisl WC

    . Neuroinflammation in neurodegenerative disorders: a review. Curr Neurol Neurosci Rep 2017;17:1–11 doi:10.1007/s11910-017-0733-2 pmid:28283959

    CrossRefPubMed
61. 61.↵
    1. Grossman M,
    2. Mickanin J,
    3. Onishi K, et al

    . Progressive nonfluent aphasia: language, cognitive, and PET measures contrasted with probable Alzheimer’s disease. J Cogn Neurosci 1996;8:135–54 doi:10.1162/jocn.1996.8.2.135 pmid:23971420

    CrossRefPubMed
62. 62.↵
    1. Mesulam MM

    . Primary progressive aphasia. Ann Neurol 2001;49:425–32 doi:10.1002/ana.91 pmid:11310619

    CrossRefPubMedWeb of Science
63. 63.↵
    1. Ash S,
    2. Moore P,
    3. Vesely L, et al

    . Non-fluent speech in frontotemporal lobar degeneration. J Neurolinguistics 2009;22:370–83 doi:10.1016/j.jneuroling.2008.12.001 pmid:22180700

    CrossRefPubMed
64. 64.↵
    1. Grossman M

    . The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol 2012;11:545–55 doi:10.1016/S1474-4422(12)70099-6 pmid:22608668

    CrossRefPubMed
65. 65.↵
    1. Olney NT,
    2. Spina S,
    3. Miller BL

    . Frontotemporal dementia. Neurol Clin 2017;35:339–74 doi:10.1016/j.ncl.2017.01.008 pmid:28410663

    CrossRefPubMed
66. 66.↵
    1. Xiong L,
    2. Xuereb JH,
    3. Spillantini MG, et al

    . Clinical comparison of progressive aphasia associated with Alzheimer versus FTD-spectrum pathology. J Neurol Neurosurg Psychiatry 2011;82:254–60 doi:10.1136/jnnp.2010.209916 pmid:20841368

    CrossRefPubMed
67. 67.↵
    1. Rohrer J,
    2. Guerreiro R,
    3. Vandrovcova J, et al

    . The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009;73:1451–56 doi:10.1212/WNL.0b013e3181bf997a pmid:19884572

    CrossRefPubMed
68. 68.↵
    1. Henry ML,
    2. Meese MV,
    3. Truong S, et al

    . Treatment for apraxia of speech in nonfluent variant primary progressive aphasia. Behav Neurol 2013;26:77–88 doi:10.1155/2013/824302 pmid:22713405

    CrossRefPubMed
69. 69.↵
    1. Wang J,
    2. Wu D,
    3. Chen Y, et al

    . Effects of transcranial direct current stimulation on language improvement and cortical activation in nonfluent variant primary progressive aphasia. Neurosci Lett 2013;549:29–33 doi:10.1016/j.neulet.2013.06.019 pmid:23800543

    CrossRefPubMed
70. 70.↵
    1. Mandelli ML,
    2. Vilaplana E,
    3. Brown JA, et al

    . Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia. Brain 2016;139:2778–91 doi:10.1093/brain/aww195 pmid:27497488

    CrossRefPubMed
71. 71.↵
    1. Mandelli ML,
    2. Vitali P,
    3. Santos M, et al

    . Two insular regions are differentially involved in behavioral variant FTD and nonfluent/agrammatic variant PPA. Cortex 2016;74:149–57 doi:10.1016/j.cortex.2015.10.012 pmid:26673947

    CrossRefPubMed
72. 72.↵
    1. Sajjadi SA,
    2. Sheikh-Bahaei N,
    3. Cross J, et al

    . Can MRI visual assessment differentiate the variants of primary-progressive aphasia? AJNR Am J Neuroradiol 2017;38:954–60 doi:10.3174/ajnr.A5126 pmid:28341715

    CrossRefPubMed
73. 73.↵
    1. Mandelli ML,
    2. Caverzasi E,
    3. Binney RJ, et al

    . Frontal white matter tracts sustaining speech production in primary progressive aphasia. J Neurosci 2014;34:9754–67 doi:10.1523/JNEUROSCI.3464-13.2014 pmid:25031413

    CrossRefPubMed
74. 74.↵
    1. Wilson SM,
    2. Galantucci S,
    3. Tartaglia MC, et al

    . Syntactic processing depends on dorsal language tracts. Neuron 2011;72:397–403 doi:10.1016/j.neuron.2011.09.014 pmid:22017996

    CrossRefPubMed
75. 75.↵
    1. Wilson SM,
    2. Dronkers NF,
    3. Ogar JM, et al

    . Neural correlates of syntactic processing in the nonfluent variant of primary progressive aphasia. J Neurosci 2010;30:16845–54 doi:10.1523/JNEUROSCI.2547-10.2010 pmid:21159955

    CrossRefPubMed
76. 76.↵
    1. Miller ZA,
    2. Mandelli ML,
    3. Rankin KP, et al

    . Handedness and language learning disability differentially distribute in progressive aphasia variants. Brain 2013;136:3461–73 doi:10.1093/brain/awt242 pmid:24056533

    CrossRefPubMed
77. 77.↵
    1. Dick AS,
    2. Garic D,
    3. Graziano P, et al

    . The frontal aslant tract (FAT) and its role in speech, language and executive function. Cortex 2019;111:148–63 doi:10.1016/j.cortex.2018.10.015 pmid:30481666

    CrossRefPubMed
78. 78.↵
    1. Bonakdarpour B,
    2. Rogalski EJ,
    3. Wang A, et al

    . Functional connectivity is reduced in early-stage primary progressive aphasia when atrophy is not prominent. Alzheimer Dis Assoc Disord 2017;31:101–16 doi:10.1097/WAD.0000000000000193 pmid:28288010

    CrossRefPubMed
79. 79.↵
    1. Minoshima S,
    2. Drzezga AE,
    3. Barthel H, et al

    . SNMMI procedure standard/EANM practice guideline for amyloid PET imaging of the brain 1.0. J Nucl Med 2016;57:1316–22 doi:10.2967/jnumed.116.174615 pmid:27481605

    CrossRefPubMed
80. 80.↵
    1. Santos-Santos MA,
    2. Rabinovici GD,
    3. Iaccarino L, et al

    . Rates of amyloid imaging positivity in patients with primary progressive aphasia. JAMA Neurol 2018;75:342–52 doi:10.1001/jamaneurol.2017.4309 pmid:29309493

    CrossRefPubMed
81. 81.↵
    1. Tsai RM,
    2. Bejanin A,
    3. Lesman-Segev O, et al

    . ¹⁸F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Alzheimers Res Ther 2019;11:1–18 doi:10.1186/s13195-018-0453-0 pmid:30704514

    CrossRefPubMed
82. 82.↵
    1. Pascual B,
    2. Funk Q,
    3. Zanotti-Fregonara P, et al

    . Multimodal 18F-AV-1451 and MRI findings in nonfluent variant of primary progressive aphasia: possible insights on nodal propagation of tau protein across the syntactic network. J Nucl Med 2020;61:263–69 doi:10.2967/jnumed.118.225508 pmid:31350322

    CrossRefPubMed
83. 83.↵
    1. Cagnin A,
    2. Rossor M,
    3. Sampson EL, et al

    . In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol 2004;56:894–97 doi:10.1002/ana.20332 pmid:15562429

    CrossRefPubMed
84. 84.↵
    1. Madhavan A,
    2. Whitwell JL,
    3. Weigand SD, et al

    . FDG PET and MR imaging in logopenic primary progressive aphasia versus dementia of the Alzheimer’s type. PLoS One 2013;8:e62471 doi:10.1371/journal.pone.0062471 pmid:23626825

    CrossRefPubMed